First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study von Soria, Jean-Charles, Prof, Tan, Daniel S W, MD, Chiari, Rita, MD, Wu, Yi-Long, Prof, Paz-Ares, Luis, Prof, Wolf, Juergen, Prof, Geater, Sarayut L, MD, Orlov, Sergey, Prof, Cortinovis, Diego, MD, Yu, Chong-Jen, Prof, Hochmair, Maximillian, MD, Cortot, Alexis B, Prof, Tsai, Chun-Ming, Prof, Moro-Sibilot, Denis, MD, Campelo, Rosario G, MD, McCulloch, Tracey, MSc, Sen, Paramita, PhD, Dugan, Margaret, MD, Pantano, Serafino, PhD, Branle, Fabrice, MD, Massacesi, Cristian, MD, de Castro, Gilberto, MD

Volltext

Microstructure Development of Cu/SiO₂ Hybrid Bond Interconnects After Reliability Tests von Panchenko, Iuliana, Wenzel, Laura, Mueller, Maik, Rudolph, Catharina, Hanisch, Anke, Wolf, Juergen M.

Volltext

Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors von Heydt, Carina, Ruesseler, Vanessa, Pappesch, Roberto, Wagener, Svenja, Haak, Anja, Siebolts, Udo, Riedel, Richard, Michels, Sebastian, Wolf, Juergen, Schultheis, Anne M., Rehker, Jan, Buettner, Reinhard, Merkelbach-Bruse, Sabine

Volltext

Visualization of Hypervascular Liver Lesions During TACE: Comparison of Angiographic C-Arm CT and MDCT von Meyer, Bernhard C, Frericks, Bernd B, Voges, Maerthe, Borchert, Michael, Martus, Peter, Justiz, Joern, Wolf, Karl-Juergen, Wacker, Frank K

Volltext

Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score von Arolt, Christoph, Scheel, Andreas H., Dugan, Margaret, Wild, Robert, Richartz, Vanessa, Holz, Barbara, Brägelmann, Johannes, Wagener-Ryczek, Svenja, Merkelbach-Bruse, Sabine, Wolf, Juergen, Buettner, Reinhard, Catanzariti, Luigi, Scheffler, Matthias, Hillmer, Axel M.

Volltext

PAN-CANCER EFFICACY OF VEMURAFENIB IN BRAFV600-MUTANT NON-MELANOMA CANCERS von Subbiah, Vivek, Puzanov, Igor, Blay, Jean-Yves, Chau, Ian, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany, Hyman, David M.

Volltext

Response to letter entitled: Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harborin... von Kron, Anna, Scheffler, Matthias, Wolf, Juergen

Volltext

Flip chip bumping technology—Status and update von Juergen Wolf, M., Engelmann, Gunter, Dietrich, Lothar, Reichl, Herbert

Volltext

Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T7... von Tan, Daniel Shao-Weng, Yang, James Chih-Hsin, Leighl, Natasha B., Riely, Gregory J., Sequist, Lecia V., Felip, Enriqueta, Seto, Takashi, Wolf, Juergen, Moody, Susan Elizabeth, Adams, Kenneth, Schmitz, Shu-Fang Hsu, Tan, Eugene Y., Kim, Dong-Wan

Volltext

Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group von JOSTING, Andreas, WIEDENMANN, Sabine, FRANKLIN, Jeremy, MAY, Michael, SIEBER, Markus, WOLF, Juergen, ENGERT, Andreas, DIEHL, Volker

Volltext

An integral method for solving nonlinear eigenvalue problems von Beyn, Wolf-Jürgen

Volltext

Genetic heterogeneity of KRAS -mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background von Scheffler, Matthias, Ihle, Michaela A., Hein, Rebecca, Merkelbach-Bruse, Sabine, Braegelmann, Johannes, Scheel, Andreas H., Michels, Sebastian Yves Friedrich, Ueckeroth, Frank, Eisert, Anna, Gogl, Leonie, Frank, Rieke, Fischer, Rieke Nila, Koleczko, Sophia, Schaepers, Carsten, Kostenko, Anna, Kron, Florian, Hellmich, Martin, Sos, Martin L., Buettner, Reinhard, Wolf, Juergen

Volltext

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease : Potential for a prognostic factor von WEIHRAUCH, Martin R, MANZKE, Oliver, BEYER, Marc, HAVERKAMP, Heinz, DIEHL, Volker, BOHLEN, Heribert, WOLF, Juergen, SCHULTZE, Joachim L

Volltext

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY... von Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L, Glisson, Bonnie S, Farago, Anna F, Dowlati, Afshin, Rudin, Charles M, Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Jürgen, Govindan, Ramaswamy, Carbone, David P

Volltext

Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial von Drilon, Alexander, Subbiah, Vivek, Gautschi, Oliver, Tomasini, Pascale, de Braud, Filippo, Solomon, Benjamin J, Shao-Weng Tan, Daniel, Alonso, Guzmán, Wolf, Jürgen, Park, Keunchil, Goto, Koichi, Soldatenkova, Victoria, Szymczak, Sylwia, Barker, Scott S, Puri, Tarun, Bence Lin, Aimee, Loong, Herbert, Besse, Benjamin

Volltext

On a generalized notion of metrics von Beyn, Wolf-Jürgen

Volltext

Stochastic C-Stability and B-Consistency of Explicit and Implicit Euler-Type Schemes von Beyn, Wolf-Jürgen, Isaak, Elena, Kruse, Raphael

Volltext

2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer von Zimmerman, Stefan, Das, Arundhati, Wang, Shuhang, Julian, Ricklie, Gandhi, Leena, Wolf, Juergen

Volltext

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer von Ahn, Myung-Ju, Cho, Byoung Chul, Felip, Enriqueta, Korantzis, Ippokratis, Ohashi, Kadoaki, Majem, Margarita, Juan-Vidal, Oscar, Handzhiev, Sabin, Izumi, Hiroki, Lee, Jong-Seok, Dziadziuszko, Rafal, Wolf, Jürgen, Blackhall, Fiona, Reck, Martin, Bustamante Alvarez, Jean, Hummel, Horst-Dieter, Dingemans, Anne-Marie C., Sands, Jacob, Akamatsu, Hiroaki, Owonikoko, Taofeek K., Ramalingam, Suresh S., Borghaei, Hossein, Johnson, Melissa L., Huang, Shuang, Mukherjee, Sujoy, Minocha, Mukul, Jiang, Tony, Martinez, Pablo, Anderson, Erik S., Paz-Ares, Luis

Volltext

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC von Zhou, Caicun, Solomon, Benjamin, Loong, Herbert H., Park, Keunchil, Pérol, Maurice, Arriola, Edurne, Novello, Silvia, Han, Baohui, Zhou, Jianying, Ardizzoni, Andrea, Mak, M. Perez, Santini, Fernando C., Elamin, Yasir Y., Drilon, Alexander, Wolf, Jürgen, Payakachat, Nalin, Uh, Minji K., Rajakumar, Deborah, Han, Hongmei, Puri, Tarun, Soldatenkova, Victoria, Lin, A. Bence, Lin, Boris K., Goto, Koichi

Volltext